Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Aristea Therapeutics Strengthens its Board of Directors with the Appointment of Three Accomplished Biopharma Leaders From Poseida Therapeutics, Novo Holdings and Pfizer
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]
LumaBridge and Parker Institute for Cancer Immunotherapy Announce Strategic Alliance to Streamline Immunotherapy Development
LumaBridge (formerly known as Cancer Insight), a clinical research organization (CRO) dedicated to discovering, developing, and […]
Nitra Raises $62 Million to Revolutionize Fintech for the Healthcare Industry
Nitra, a fintech company founded by successful serial entrepreneurs, announced today that it has raised $62 […]
Plume, the Leading Gender-Affirming Virtual Care Provider Announces $24M in Series B Funding to Expand Coverage Nationwide
Plume, the market-leading provider of virtual care services purposefully designed for the health care needs […]
Hansa Biopharma and Medison Pharma Announce Positive Reimbursement Decision in Poland for Idefirix® in Highly Sensitized Kidney Transplant Patients
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological […]
Prominent Neurosurgeon Joins Leucadia Therapeutics as Company's Founding Global Chief Medical Officer
Leucadia Therapeutics, a company working to cure Alzheimer’s disease, has hired a global chief medical […]
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head
Brii Biosciences Limited (“Brii Bio” or the “Company”, stock code: 2137.HK), a multi-national company developing innovative therapies […]
AIRS Medical Raises $20M in Series B Funding
AIRS Medical, a healthcare startup based in South Korea and a member of the Born2Global Centre, recently announced that […]
Porton Advanced Solutions Completes a Series B Financing Round to Expand Its End-to-end Gene and Cell Therapy CDMO Platforms
Porton Advanced Solutions (Porton Advanced) announced the completion of its Series B financing round with […]
Ubie, Japanese Health-tech Startup, Raises $26.2 Million in Series C, $59.8 Million in Total
Ubie, Inc., a healthcare AI startup with the mission “To develop a healthcare guide for everyone,” […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more